Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02653157 · ClinicalTrials.gov registry record
Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn
A clinical trial of Multi-drug Resistant Gram-negative Bacilli Colonization, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 48
- Enrollment target
- 1
- Study location
NCT02653157: Completed study of Multi-drug Resistant Gram-negative Bacilli Colonization, sponsored by University of North Carolina, Chapel Hill.
NCT02653157 is a study of Multi-drug Resistant Gram-negative Bacilli Colonization that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02653157, a study of Multi-drug Resistant Gram-negative Bacilli Colonization, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational study to determine the role of colonization and identify the timing of development of drug resistance in multidrug resistant Gram-negative bacilli (MDR-GNB) causing infection among critically ill burn patients.
Primary Outcome
Endotracheal tube or tracheostomy aspirates will be obtained upon admission and twice weekly; wound and perirectal area swabs will be collected weekly and will be used to characterize species.
Conditions Studied
Interventions
- OTHER MDR-GNB
Study Locations (1)
North Carolina
- University of North Carolina Jaycee Burn Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-12 |
What the finished NCT02653157 record still lists
NCT02653157 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 1 condition, with Multi-drug Resistant Gram-negative Bacilli Colonization appearing as the primary indexed condition, and to 1 intervention - of which MDR-GNB is the first listed.
NCT02653157 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02653157 about?
NCT02653157 is a clinical study titled "Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn". This is a prospective observational study to determine the role of colonization and identify the timing of development of drug resistance in multidrug resistant Gram-negative bacilli (MDR-GNB) causing infection among critically ill burn patients.
What is the current status of trial NCT02653157?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2015-10. Estimated completion is 2017-12.
What conditions does trial NCT02653157 study?
This clinical trial studies the following conditions: Multi-drug Resistant Gram-negative Bacilli Colonization.
What interventions are being tested in trial NCT02653157?
The interventions under investigation include: MDR-GNB (OTHER).
Who is sponsoring clinical trial NCT02653157?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02653157 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia